Diabetes and COVID-19: Considerations and Clinical Management: Contemporary Endocrinology
Editat de Alyson K. Myersen Limba Engleză Paperback – 12 iun 2024
Managing COVID-19 alone can be a difficult in many cases, but for persons with pre-existing conditions such as diabetes the challenge can be all the greater, and specific considerations need to be taken when prescribing treatment to manage them. This book is a culmination of scientific work driven by personal conviction to enhance the care provided to the vulnerable populations COVID-19 patients with diabetes. It spans topics from the epidemiology and predictors of complications and increased mortality in COVID-19, to in-depth discussion of the pathophysiology of the disease. Pathophysiology of COVID-19 is addressed comprehensively as common soil pathogenetic pathways, and by organ system such as the lung, the kidney and most pertinently for diabetes, the diabetic foot ulcers and diabetes co-morbidities. A multi-disciplinary approach was needed to manage these complex patients; thus, the authors represent a variety of disciplines including pharmacology, endocrinology, nephrology,infectious diseases, podiatry, vascular surgery, pulmonary/critical care, and general medicine.
Written by experts in the field, Diabetes and COVID-19: Considerations and Clinical Management is a blueprint for treatment of patients with both conditions.
Toate formatele și edițiile | Preț | Express |
---|---|---|
Paperback (1) | 640.68 lei 39-44 zile | |
Springer International Publishing – 12 iun 2024 | 640.68 lei 39-44 zile | |
Hardback (1) | 842.74 lei 39-44 zile | |
Springer International Publishing – 11 iun 2023 | 842.74 lei 39-44 zile |
Din seria Contemporary Endocrinology
- 5% Preț: 1600.35 lei
- 5% Preț: 1031.39 lei
- 5% Preț: 1071.32 lei
- 5% Preț: 674.95 lei
- 5% Preț: 1088.02 lei
- 5% Preț: 1121.99 lei
- 5% Preț: 776.31 lei
- 5% Preț: 918.48 lei
- 5% Preț: 708.71 lei
- 5% Preț: 1087.12 lei
- 5% Preț: 1087.66 lei
- 5% Preț: 1609.14 lei
- 5% Preț: 1090.01 lei
- 5% Preț: 1440.16 lei
- 5% Preț: 1014.59 lei
- 5% Preț: 1413.94 lei
- 5% Preț: 1091.43 lei
- 5% Preț: 1081.73 lei
- 5% Preț: 1585.79 lei
- 5% Preț: 1094.33 lei
- 5% Preț: 1002.20 lei
- 5% Preț: 1410.34 lei
- 5% Preț: 1100.58 lei
- 5% Preț: 1622.81 lei
- 5% Preț: 1418.06 lei
- 5% Preț: 1042.35 lei
- 5% Preț: 731.16 lei
- 5% Preț: 1089.82 lei
- 5% Preț: 1586.69 lei
- 5% Preț: 1086.40 lei
- 5% Preț: 1411.60 lei
- 5% Preț: 1397.21 lei
- 5% Preț: 1706.58 lei
- 5% Preț: 1585.26 lei
- 5% Preț: 1092.51 lei
- 5% Preț: 1081.53 lei
- 5% Preț: 1381.96 lei
- 5% Preț: 1345.79 lei
- 5% Preț: 1087.83 lei
- 5% Preț: 1269.06 lei
- 5% Preț: 1406.37 lei
- 5% Preț: 1407.13 lei
- 5% Preț: 989.18 lei
Preț: 640.68 lei
Preț vechi: 674.39 lei
-5% Nou
Puncte Express: 961
Preț estimativ în valută:
122.67€ • 127.74$ • 101.78£
122.67€ • 127.74$ • 101.78£
Carte tipărită la comandă
Livrare economică 10-15 februarie
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9783031285387
ISBN-10: 3031285387
Ilustrații: XVIII, 219 p. 23 illus., 21 illus. in color.
Dimensiuni: 155 x 235 mm
Ediția:2023
Editura: Springer International Publishing
Colecția Springer
Seria Contemporary Endocrinology
Locul publicării:Cham, Switzerland
ISBN-10: 3031285387
Ilustrații: XVIII, 219 p. 23 illus., 21 illus. in color.
Dimensiuni: 155 x 235 mm
Ediția:2023
Editura: Springer International Publishing
Colecția Springer
Seria Contemporary Endocrinology
Locul publicării:Cham, Switzerland
Cuprins
COVID-19: epidemiology, etiology, clinical manifestations, diagnosis, therapeutic options, and prevention.- Pathophysiology: How COVID-19 Impacts the Pancreas and Peripheral Insulin Resistance.- Risk of COVID-19 in Persons with Diabetes.- Pathophysiology of Lung Dysfunction in Diabetes.- Diabetic kidney disease and COVID-19.- The Impact of COVID-19 on Diabetic Foot Ulcers.- Co-morbid obesity and its impact on diabetes and COVID-19.- Overview of Inpatient Mgt of Diabetes and COVID 19.- Management of critically ill persons with COVID-19 and diabetes.- Managing Outpatient Diabetes in Persons with COVID-19 and Diabetes.- The Use of Diabetes Technology In Persons With Diabetes and Coronavirus 2019 (COVID-19).- COVID-19 Vaccination in Persons with Diabetes.- COVID-19 Vaccination in Persons with Diabetes.- Long-haul COVID Symptoms in Person with Diabetes.
Notă biografică
Alyson K. Myers, MD, Division of Endocrinology, Department of Medicine, Montefiore Einstein, Bronx, NY
Textul de pe ultima copertă
Managing COVID-19 alone can be a difficult in many cases, but for persons with pre-existing conditions such as diabetes the challenge can be all the greater, and specific considerations need to be taken when prescribing treatment to manage them. This book is a culmination of scientific work driven by personal conviction to enhance the care provided to the vulnerable populations COVID-19 patients with diabetes. It spans topics from the epidemiology and predictors of complications and increased mortality in COVID-19, to in-depth discussion of the pathophysiology of the disease. Pathophysiology of COVID-19 is addressed comprehensively as common soil pathogenetic pathways, and by organ system such as the lung, the kidney and most pertinently for diabetes, the diabetic foot ulcers and diabetes co-morbidities. A multi-disciplinary approach was needed to manage these complex patients; thus, the authors represent a variety of disciplines including pharmacology, endocrinology, nephrology, infectious diseases, podiatry, vascular surgery, pulmonary/critical care, and general medicine.
Written by experts in the field, Diabetes and COVID-19: Considerations and Clinical Management is a blueprint for treatment of patients with both conditions.
Caracteristici
Comprehensive review of diabetes and COVID-19 Discussion of both inpatient and outpatient management of diabetes and COVID-19 Authored by a diverse group of providers